Search

Meeting Coverage:

Association for Research in Vision & Ophthalmology

ARVO: 2020

Novel C5 Inhibitor for GA Growth

Karl Csaky, MD, PhD

Show Description +

Karl Csaky, MD, PhD, reviews data from a clinical trial that evaluated the novel C5 inhibitor avacincaptad pegol (Zimura, IVERIC bio) for the treatment of patients with geographic atrophy. Dr. Csaky summarizes the study's inclusion criteria, explains the study's 12-month results, and previews future evaluations of this drug candidate.

Posted: 5/13/2020

Keywords:

Clinical Cases

•

Geographic Atrophy (GA)

•

retina-meeting-recap

Up Next

HtrA1 Inhibition for Dry AMD

HtrA1 Inhibition for Dry AMD

Dante J. Pieramici, MD

OPTIC Study Data

OPTIC Study Data

Arshad M. Khanani, MD

PALADIN Study in Diabetic Eye Disease

PALADIN Study in Diabetic Eye Disease

Victor H. Gonzalez, MD

Clinical Trials Evaluating IONIS-FB-Lrx

Clinical Trials Evaluating IONIS-FB-Lrx

Glenn Jaffe, MD

Brolucizumab and Aflibercept in HAWK and HARRIER

Brolucizumab and Aflibercept in HAWK and HARRIER

Rishi P. Singh, MD

Phase 1/2A Data on Transplantation of hESC-Derived RPE Cells for Dry AMD

Phase 1/2A Data on Transplantation of hESC-Derived RPE Cells for Dry AMD

Christopher D. Riemann, MD

100-Week Data vs. 52-Week Data in PANORAMA

100-Week Data vs. 52-Week Data in PANORAMA

Jennifer I. Lim, MD

Retinal Nonperfusion Status in Patients with DME

Retinal Nonperfusion Status in Patients with DME

Charles C. Wykoff, MD, PhD

Real-World RVO Treatment Outcomes

Real-World RVO Treatment Outcomes

Thomas A. Ciulla, MD, MBA

Back to All Videos

Novel C5 Inhibitor for GA Growth

Karl Csaky, MD, PhD

Karl Csaky, MD, PhD, reviews data from a clinical trial that evaluated the novel C5 inhibitor avacincaptad pegol (Zimura, IVERIC bio) for the treatment of patients with geographic atrophy. Dr. Csaky summarizes the study's inclusion criteria, explains the study's 12-month results, and previews future evaluations of this drug candidate.

Posted: 5/13/2020

Keywords:

Clinical Cases

•

Geographic Atrophy (GA)

•

retina-meeting-recap

Please log in to leave a comment.

More From ARVO: 2020 Coverage

Real-World RVO Treatment Outcomes

Real-World RVO Treatment Outcomes

Thomas A. Ciulla, MD, MBA

HtrA1 Inhibition for Dry AMD

HtrA1 Inhibition for Dry AMD

Dante J. Pieramici, MD

OPTIC Study Data

OPTIC Study Data

Arshad M. Khanani, MD

PALADIN Study in Diabetic Eye Disease

PALADIN Study in Diabetic Eye Disease

Victor H. Gonzalez, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARVO: 2020.